InnoMed Technologies Receives The 2004 Frost And Sullivan Award For Product Innovation
 |
|
 |
PALO ALTO, Calif.--(BUSINESS
WIRE)--Wednesday, April 07, 2004 In a recent study
entitled 'Strategic Analysis of World Sleep Apnea Therapeutic
Markets,' Frost and Sullivan recognized InnoMed Technologies Inc.'s
revolutionary facial interface, a product that can provide comfort
to millions of people suffering from sleep apnea, with the 2004
Frost and Sullivan Award for Product Innovation. Since masks are a
very important component of continuous positive airway pressure (CPAP)
therapy for sleep apnea, a comfortable mask can be crucial for
patient compliance. While a number of companies have focused their
efforts on developing better masks, InnoMed Technologies has
excelled with the development of Nasal-Aire, a truly innovative
mask. It does not require any headgear and can be worn like an
oxygen canula, providing highly effective therapy.
'The lack of patient comfort and compliance is one of the biggest
reasons for the failure of CPAP therapy, however, Nasal-Aire offers
multiple benefits to patients including the freedom to speak, sleep
in any direction and wear eyeglasses, which makes it a facial
interface of choice,' says Frost and Sullivan industry analyst
Dhiraj Ajmani. For its innovative product that can help increase
patient compliance in the CPAP market, InnoMed is the recipient of
the 2004 Frost and Sullivan Award for Product Innovation. The award
is presented each year to the company that has demonstrated
excellence in new products and technologies within its industry. The
recipient company has shown innovation by launching a broad line of
emerging products and technologies. InnoMed's' product pipeline
includes other novel products such as Nasal PAP Freestyle, a compact
and comfortable interface, and the Nasal-Aire Critical Care device.
Frost and Sullivan expects these products to expand the already
growing market for Nasal-Aire. The company came into existence three
years ago and is ISO1345-1996-certified, and the Nasal-Aire II has
received its CE Mark. InnoMed's products have found good acceptance
in over 40 countries. The research-driven privately owned company is
continuously developing innovative products in the fields of the
rapidly growing sleep apnea and critical care markets. The simple
and highly innovative, patient friendly Nasal-Aire is expected to
revolutionize CPAP therapy, driving revenues for InnoMed
Technologies.
About InnoMed Technologies Inc.
InnoMed is a research-oriented, privately held, 21st century medical
technologies company. The company is poised to bring new and more
effective medical products and devices to the public through a
medical development and engineering team, as well as acquisitions of
other medical-related companies. InnoMed holds several patents and
has several patents pending. More information regarding InnoMed
Technologies is available at
http://www.innomedinc.com.
About Frost and Sullivan
Founded in 1961, Frost and Sullivan is recognized as a global leader
in growth consulting. Frost and Sullivan Awards are presented to
companies that demonstrate excellence in the industry through
diligence, commitment and innovative business strategies required to
advance in the global marketplace. Frost and Sullivan rigorously
analyzes specific criteria to determine award recipients in a vast
variety of market industries and landscapes. For further
information, visit
www.frost.com.
Jamie Frizzell
210-247-2496
jfrizzell@frost.com
|
|
